A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
Carlos Carvalhal admits his gamble backfired as Swansea dropped back into the relegation zone after being thumped 4-1 by Brighton.
The former Tory leader is helping to raise awareness of breast cancer in men, by talking about the death of his Llanelli businessman father.
Wales' late brace in the dying moments of the game wasn't enough to come away with a victory against Ireland in Dublin.